查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1977737

全球新生儿筛检设备市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Newborn Screening Instruments Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计到 2034 年，新生儿筛检设备市场规模将从 2025 年的 10.1 亿美元成长至 20.4 亿美元，2026 年至 2034 年的复合年增长率为 8.19%。

全球新生儿筛检设备市场正经历强劲成长，这主要得益于人们对早期发现婴幼儿疾病重要性的认识不断提高。许多国家政府强制推行新生儿筛检项目，以便及早发现代谢性疾病、遗传性疾病和内分泌疾病。串联式质谱质谱和分子诊断平台的技术进步提高了检测的准确性和处理能力。发展中地区医疗基础设施的不断改善也进一步推动了市场成长。

成长要素包括新兴经济体出生率的上升以及先进筛检方案的日益普及。医院和诊断检查室正在投资自动化、高通量系统以提高效率。对预防医学和早期疗育的日益重视也促进了需求成长。此外，政府资金和公共卫生政策正在推动综合筛检计画的整合。

展望未来，就地检验的创新和基因筛检能力的拓展有望推动市场发展。数位健康记录的整合将简化资料管理。新兴市场正在建造新生儿医疗设施，这将创造巨大的成长机会。随着早期诊断成为医疗重点，全球新生儿筛检设备市场预计将持续扩张。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章：全球新生儿筛检设备市场：依检测类型划分

  • 市场分析、洞察与预测
  • 血斑测试
  • 听力测试
  • 严重先天性心臟疾病（CCHD）筛检
  • 代谢紊乱检测

第五章：全球新生儿筛检设备市场：依产品类型划分

  • 市场分析、洞察与预测
  • 质谱仪
  • 脉动式血氧监测仪系统
  • 听力筛检设备
  • 检测试剂盒
  • DNA定序仪

第六章 全球新生儿筛检设备市场：按地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第七章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第八章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • PerkinElmer Inc
    • Waters Corporation
    • Bio-Rad Laboratories Inc
    • Agilent Technologies Inc
    • Trivitron Healthcare
    • Natus Medical Incorporated
    • Zivak Technologies
    • Neogen Corporation
    • Medtronic
    • SCIEX（A Danaher Company）
简介目录
Product Code: VMR112113001

The Newborn Screening Instruments Market size is expected to reach USD 2.04 Billion in 2034 from USD 1.01 Billion (2025) growing at a CAGR of 8.19% during 2026-2034.

The Global Newborn Screening Instruments Market is witnessing strong growth driven by increasing awareness of early disease detection in infants. Governments across many countries have implemented mandatory newborn screening programs to identify metabolic, genetic, and endocrine disorders at an early stage. Technological advancements in tandem mass spectrometry and molecular diagnostic platforms are enhancing testing accuracy and throughput. Expanding healthcare infrastructure in developing regions is further supporting market expansion.

Key growth drivers include rising birth rates in emerging economies and growing adoption of advanced screening panels. Hospitals and diagnostic laboratories are investing in automated and high-throughput systems to improve efficiency. Increasing focus on preventive healthcare and early intervention is also strengthening demand. Additionally, government funding and public health initiatives are encouraging the integration of comprehensive screening programs.

Looking ahead, the market is expected to benefit from innovations in point-of-care testing and expanded genetic screening capabilities. Integration of digital health records will streamline data management. Emerging markets upgrading neonatal care facilities will create significant growth opportunities. As early diagnosis becomes a healthcare priority, the Global Newborn Screening Instruments Market is projected to experience sustained expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test Type

  • Blood Spot Test
  • Hearing Test
  • Critical Congenital Heart Disease (CCHD) Test
  • Metabolic Disorder Test

By Product Type

  • Mass Spectrometers
  • Pulse Oximeters
  • Hearing Screening Devices
  • Assay Kits
  • DNA Sequencers

COMPANIES PROFILED

  • PerkinElmer Inc, Waters Corporation, BioRad Laboratories Inc, Agilent Technologies Inc, Trivitron Healthcare, Natus Medical Incorporated, Zivak Technologies, Neogen Corporation, Medtronic, SCIEX a Danaher Company
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEWBORN SCREENING INSTRUMENTS MARKET: BY TEST TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Test Type
  • 4.2. Blood Spot Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Hearing Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Critical Congenital Heart Disease (CCHD) Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Metabolic Disorder Test Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEWBORN SCREENING INSTRUMENTS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Product Type
  • 5.2. Mass Spectrometers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Pulse Oximeters Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Hearing Screening Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Assay Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. DNA Sequencers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEWBORN SCREENING INSTRUMENTS MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Test Type
    • 6.2.2 By Product Type
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Test Type
    • 6.3.2 By Product Type
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Test Type
    • 6.4.2 By Product Type
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Test Type
    • 6.5.2 By Product Type
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Test Type
    • 6.6.2 By Product Type
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL NEWBORN SCREENING INSTRUMENTS INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 PerkinElmer Inc
    • 8.2.2 Waters Corporation
    • 8.2.3 Bio-Rad Laboratories Inc
    • 8.2.4 Agilent Technologies Inc
    • 8.2.5 Trivitron Healthcare
    • 8.2.6 Natus Medical Incorporated
    • 8.2.7 Zivak Technologies
    • 8.2.8 Neogen Corporation
    • 8.2.9 Medtronic
    • 8.2.10 SCIEX (A Danaher Company)